CCTA-1523
CAS No. 1616271-41-0
CCTA-1523( —— )
Catalog No. M28783 CAS No. 1616271-41-0
CCTA-1523 is an efflux function of ABCG2 inhibitor. CCTA-1523 selectively reverses ABCG2-mediated MDR in cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
|
10MG | 447 | Get Quote |
|
25MG | 714 | Get Quote |
|
50MG | 1017 | Get Quote |
|
100MG | 1368 | Get Quote |
|
500MG | 2673 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCTA-1523
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCTA-1523 is an efflux function of ABCG2 inhibitor. CCTA-1523 selectively reverses ABCG2-mediated MDR in cancer cells.
-
DescriptionCCTA-1523 is an efflux function of ABCG2 inhibitor. CCTA-1523 selectively reverses ABCG2-mediated MDR in cancer cells.(In Vitro):CCTA-1523 (5μM) sensitized the ABCG2 overexpressing cancer cells and ABCG2 transfected cells to the substrate chemotherapeutic drugs.(In Vivo):Co-administration of CCTA-1523 restored the in vivo antitumor activity of doxorubicin in ABCG2 overexpressing tumor xenografts.
-
In Vitro——
-
In VivoAnimal Model:NCR nude mice (H460/MX20 xenografts) Dosage:75 mg/kg (DOX ;1.8 mg/kg, i.p., q3d X 6 ) Administration:P.o.;q3d x 6 Result:Significantly inhibited the growth of H460/MX20 tumor xenografts when combined with doxorubicin compared to the vehicle control group.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1616271-41-0
-
Formula Weight340.2
-
Molecular FormulaC16H15Cl2NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc(ccc(-c1cccc(NC(C(Cl)Cl)=O)c1)c1)c1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang ZD, et al. Synthesis of Demissidine and Solanidine.Org Lett. 2016 Jun 17;18(12):3038-40.
molnova catalog
related products
-
Di-O-methylhonokiol
Di-O-methylhonokiol (Honokiol dimethyl ether), a phenolic component of Magnolia grandiflora L, exhibits antimicrobial activity and significant antioxidant activity against Gram-positive and acid-resistant bacteria and fungi.
-
Uprosertib
Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.
-
Cetilistat
Cetilistat is an inhibitor of pancreatic and gastrointestinal lipases. It has great treatment of obesity in both diabetic and non-diabetic patients.